News

Metabolic monitoring suboptimal for dementia patients taking antipsychotics

Publish date: April 14, 2015

 

AT THE AAGP ANNUAL MEETING

References

Dr. Mittal had no financial disclosures.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Pages

Recommended Reading

ADA and EASD recommend improvements in monitoring insulin pump safety
MDedge Endocrinology
Microbiome may drive the course of diabetes, obesity
MDedge Endocrinology
Cardiovascular safety evidence for alogliptin reassuring
MDedge Endocrinology
Anticipation runs high for coming megatrials in general cardiology
MDedge Endocrinology
Updated IMPROVE-IT results show bigger benefits
MDedge Endocrinology
Genetic link validated between shorter height, coronary artery disease
MDedge Endocrinology
Antimalarial drugs reduced instances of metabolic syndrome in lupus patients
MDedge Endocrinology
CCND2 variant improves insulin secretion and sensitivity
MDedge Endocrinology
Screening adults for diabetes doesn’t lessen mortality
MDedge Endocrinology
Heart failure spurs 'cardiogenic diabetes'
MDedge Endocrinology